Representative Matters

Represented a participating investor in a Hong Kong financing round for a leading AI company, covering due diligence, transaction structuring and investment execution.

Led legal structuring support for a Hong Kong platform of an RMB international investment-loan fund, including cross-border structuring and regulatory compliance work.

Advised on PRC capital contribution and outbound compliance issues for an RMB international investment-loan fund.

Led offshore USD fund formation support, including fund structure design and fund document drafting.

Advised a state-owned venture capital platform on industrial M&A fund formation and due diligence on a leading private equity institution.

Advised a district-level industrial guidance fund in Shenzhen on cooperation with an offshore fund manager.

Issued legal opinions for a state-owned venture capital enterprise on a technology innovation corporate bond issuance on the Shenzhen Stock Exchange.

Led legal coordination for a UK semiconductor group's investment project in China, covering policy, compliance and implementation issues.

Led legal and policy support for major Shenzhen industrial projects across display, semiconductor, energy and life sciences sectors.

Advised on the development of the Qianhai Shenzhen-Hong Kong Modern Service Industry Cooperation Zone and related strategic emerging-industry policy work.

Assessed US export control risks for an investment project by a Shenzhen investment institution and helped identify deal-critical regulatory exposure.

Coordinated legal support for the introduction of a Singapore chip-testing company into Shenzhen for production base establishment.

Advised an LCD display panel company on investment structure, local implementation and operating-compliance issues for a Vietnam production base.

Advised a wear-resistant materials company on investment structure, local compliance requirements and execution support for factory setup in Malaysia.

Advised a senior-care and healthcare group on investment in an Australian elderly-care project.

Advised a leading Chinese pharmaceutical company on the acquisition of European rare-disease pipeline assets and cross-border transaction risk review.

Advised a Hong Kong-listed biopharma company on investment in an onshore biopharmaceutical project.

Advised on transaction cooperation with an Israeli medical fund, covering structure, due diligence and compliance analysis.

Issued legal opinions for an Anhui provincial state-owned enterprise on disposal of an overseas real estate project.

Coordinated cross-border legal support for a Shandong company following an investment fraud incident in Kazakhstan.

Advised a state-owned new-materials company on legal issues arising from a debtor's entry into Russian bankruptcy proceedings.

Advised on recognition and enforcement strategy for a CIETAC arbitral award in the United States.